Infliximab for the treatment of Crohn's disease: a systematic review and cost-utility analysis
By: Canadian Coordinating Office for Health Technology Assessment
Publisher: Canadian Coordinating Office for Health Technology Assessment
Place of publication: Ottawa
Number of pages: 66
Subjects: Crohn disease -- drug therapy; Antibodies, monoclonal -- therapeutic use
Notes: "March 2002" Technology Report

2